Insights & News page
The current landscape for procurement teams within the NHS is one that is consistently driving for savings to support Trusts’ financial positions, as non-pay costs continue to rise at a dramatic rate.
The current landscape for procurement teams within the NHS is one that is consistently driving for savings to support Trusts’ financial positions, as non-pay costs continue to rise at a dramatic rate.
Outside of their ‘business as usual’ annual savings delivery targets, Procurement teams are challenged with scoping alternative areas of spend to identify opportunities to influence and improve the bottom line. One area that has previously been relatively untouched by procurement teams is pharmacy, usually due to the way it is structured and the nature of which it is managed within the NHS, as well as at a local Trust level.
Safeguarding NHS value
NHS England’s Medicines Value and Access directorate oversees the strategic direction for the national pharmacy procurement strategy, and commercial arrangements are established by the Medicines Procurement and Supply Chain (MPSC) team for medicines used across the NHS.
This covers a large proportion of pharmacy spend and provides a centrally-agreed commercial purchasing model for drugs and medicines. However, there remain areas of spend that are deemed as addressable outside of the focus of MPSC and existing regional collaborations that are purchased via pharmacy departments in Trusts. This is the area of pharmacy spend that procurement teams tend to have little visibility of due to the way it is managed, but where they can influence and further enhance potential benefits at a local level if given the opportunity to work alongside their clinical colleagues.
Delivering value
A lack of system harmonisation and limited insights within Trusts can become a barrier to informed data analysis, but strong stakeholder engagement and collaborative approaches to reviewing spend between procurement teams and pharmacy buyers can provide useful insight into additional areas of exploration.
From specialist items that are an extension of spend currently managed by Trust teams, such as woundcare and haemostats, to pharmacy-specific items that are used in dispensary and aseptic wards, procurement teams can offer the potential to bring their expertise and ensure optimum value is achieved moving forwards.
Find out how we’re working closely with our NHS clients to provide significant insights into these areas of spend and deliver commercial benefit:
Written by
Hayley Wells
Managing Consultant, Health
Hayley Wells
Managing Consultant, Health
Hayley brings over 15 years of experience in clinical procurement across both the private and public healthcare sectors. She has a proven track record in delivering effective category management across medical portfolios and implementing strategies that drive meaningful cost savings. Passionate about collaboration, Hayley works closely with stakeholders to enable positive change, support growth, and achieve the best possible outcomes.
-
Stop chasing dashboards. Start running better services
-
Capita celebrates standout success at the CCA Excellence Awards 2026
InsightsCapita celebrates standout success at the CCA Excellence Awards 2026
Capita’s contact centre business enjoyed a highly successful evening at the CCA Excellence Awards 2026
Read more -
Why trust matters more than technology
InsightsWhy trust matters more than technology
We look at why trust, not technology, now shapes AI adoption in public services and how responsible implementation can improve outcomes for citizens.
Read more -
Capita South Africa shows how to deliver great customer experience
InsightsCapita South Africa shows how to deliver great customer experience
This article shares CX lessons from Capita's South Africa teams about building CX that is human-first, regionally inclusive, and consistently high-performing.
Read more




Share